相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Research review on the pharmacological effects of astragaloside IV
Lei Li et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2017)
Astragaloside IV attenuates free fatty acid-induced ER stress and lipid accumulation in hepatocytes via AMPK activation
Bing Zhou et al.
ACTA PHARMACOLOGICA SINICA (2017)
Astragaloside IV facilitates glucose transport in C2C12 myotubes through the IRS1/AKT pathway and suppresses the palmitate-induced activation of the IKK/IB pathway
Rongfeng Zhu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Elena Buzzetti et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Astragaloside IV improves lipid metabolism in obese mice by alleviation of leptin resistance and regulation of thermogenic network
Hui Wu et al.
SCIENTIFIC REPORTS (2016)
AMPK: positive and negative regulation, and its role in whole-body energy homeostasis
D. Grahame Hardie
CURRENT OPINION IN CELL BIOLOGY (2015)
Astragaloside IV and cycloastragenol are equally effective in inhibition of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in the endothelium
Yan Zhao et al.
JOURNAL OF ETHNOPHARMACOLOGY (2015)
The protective effect of astragaloside IV against benzo[a]pyrene induced endothelial progenitor cell dysfunction
Kangting Ji et al.
LIFE SCIENCES (2015)
Astragaloside IV Inhibits NF-kappa B Activation and Inflammatory Gene Expression in LPS-Treated Mice
Wei-Jian Zhang et al.
MEDIATORS OF INFLAMMATION (2015)
Regulation of energy metabolism by long-chain fatty acids
Manabu T. Nakamura et al.
PROGRESS IN LIPID RESEARCH (2014)
Free radical biology for medicine: learning from nonalcoholic fatty liver disease
Gaetano Serviddio et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Non Alcoholic Fatty Liver Disease in Southern Iran: A Population Based Study
Kamran Bagheri Lankarani et al.
HEPATITIS MONTHLY (2013)
Epidemiology of alcoholic and nonalcoholic fatty liver disease in China
Jian-Gao Fan
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Anti-Inflammatory Cycloartane-Type Saponins of Astragalus membranaceus
Dae-Young Lee et al.
MOLECULES (2013)
Pharmacological effects of Astragaloside IV: a literature review
Shuang Ren et al.
JOURNAL OF TRADITIONAL CHINESE MEDICINE (2013)
AMP-activated protein kinase: new regulation, new roles?
David Carling et al.
BIOCHEMICAL JOURNAL (2012)
Astragaloside IV Downregulates β-Catenin in Rat Keratinocytes to Counter LiCl-Induced Inhibition of Proliferation and Migration
Fu-Lun Li et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2012)
Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis
Rohit Loomba et al.
HEPATOLOGY (2012)
AMP-activated protein kinase mediates erythropoietin-induced activation of endothelial nitric oxide synthase
Kuo-Hui Su et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
The healing and anti-scar effects of astragaloside IV on the wound repair in vitro and in vivo
Xi Chen et al.
JOURNAL OF ETHNOPHARMACOLOGY (2012)
AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
Yu Li et al.
CELL METABOLISM (2011)
Astragaloside IV Stimulates Angiogenesis and Increases Hypoxia-Inducible Factor-1α Accumulation via Phosphatidylinositol 3-Kinase/Akt Pathway
Ling Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
Naoki Kumashiro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Crystallized View of AMPK Activation
Lawrence H. Young
CELL METABOLISM (2009)
Overexpression of AMPKα1 Ameliorates Fatty Liver in Hyperlipidemic Diabetic Rats
Eunhui Seo et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2009)
Astragaloside IV Attenuates Lipolysis and Improves Insulin Resistance Induced by TNFα in 3T3-L1 Adipocytes
Boren Jiang et al.
PHYTOTHERAPY RESEARCH (2008)
Astragaloside IV inhibits profileration and promotes apoptosis in rat vascular smooth muscle cells under high glucose concentration in vitro
Wei Yuan et al.
PLANTA MEDICA (2008)
Effects of nonalcoholic fatty liver disease on the development of metabolic disorders
Jian-Gao Fan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease
Varman T. Samuel et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men
Kitt Falk Petersen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro
ME Xu et al.
ACTA PHARMACOLOGICA SINICA (2006)
SREBPs suppress IRS-2-mediated insulin signalling in the liver
T Ide et al.
NATURE CELL BIOLOGY (2004)
Expression profiling of the γ-subunit isoforms of AMP-activated protein kinase suggests a major role for γ3 in white skeletal muscle
M Mahlapuu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
VT Samuel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Prevalence of and risk factors for hepatic steatosis in northern Italy
S Bellentani et al.
ANNALS OF INTERNAL MEDICINE (2000)
分享论文
